NeurogesX
Develops and commercializes therapies for chronic peripheral neuropathic pain.
Launch date
Employees
Market cap
-
Enterprise valuation
$4—6m (Dealroom.co estimates Mar 2012.)
San Carlos California (HQ)
Authorizing premium user...